Correlation Between Revelation Biosciences and Elevation Oncology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Revelation Biosciences and Elevation Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Revelation Biosciences and Elevation Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Revelation Biosciences and Elevation Oncology, you can compare the effects of market volatilities on Revelation Biosciences and Elevation Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Revelation Biosciences with a short position of Elevation Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Revelation Biosciences and Elevation Oncology.

Diversification Opportunities for Revelation Biosciences and Elevation Oncology

0.8
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Revelation and Elevation is 0.8. Overlapping area represents the amount of risk that can be diversified away by holding Revelation Biosciences and Elevation Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Elevation Oncology and Revelation Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Revelation Biosciences are associated (or correlated) with Elevation Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Elevation Oncology has no effect on the direction of Revelation Biosciences i.e., Revelation Biosciences and Elevation Oncology go up and down completely randomly.

Pair Corralation between Revelation Biosciences and Elevation Oncology

Given the investment horizon of 90 days Revelation Biosciences is expected to under-perform the Elevation Oncology. In addition to that, Revelation Biosciences is 1.26 times more volatile than Elevation Oncology. It trades about -0.03 of its total potential returns per unit of risk. Elevation Oncology is currently generating about 0.07 per unit of volatility. If you would invest  59.00  in Elevation Oncology on August 30, 2024 and sell it today you would earn a total of  3.44  from holding Elevation Oncology or generate 5.83% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Revelation Biosciences  vs.  Elevation Oncology

 Performance 
       Timeline  
Revelation Biosciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Revelation Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Elevation Oncology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Elevation Oncology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's technical and fundamental indicators remain fairly stable which may send shares a bit higher in December 2024. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Revelation Biosciences and Elevation Oncology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Revelation Biosciences and Elevation Oncology

The main advantage of trading using opposite Revelation Biosciences and Elevation Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Revelation Biosciences position performs unexpectedly, Elevation Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Elevation Oncology will offset losses from the drop in Elevation Oncology's long position.
The idea behind Revelation Biosciences and Elevation Oncology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Other Complementary Tools

Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings